UA41283C2 - Похідні антибіотику а 40926 та способи їх одержання - Google Patents

Похідні антибіотику а 40926 та способи їх одержання

Info

Publication number
UA41283C2
UA41283C2 UA94005300A UA94005300A UA41283C2 UA 41283 C2 UA41283 C2 UA 41283C2 UA 94005300 A UA94005300 A UA 94005300A UA 94005300 A UA94005300 A UA 94005300A UA 41283 C2 UA41283 C2 UA 41283C2
Authority
UA
Ukraine
Prior art keywords
derivatives
antibiotics
obtaining
methods
alkylaminocarbonyl
Prior art date
Application number
UA94005300A
Other languages
English (en)
Inventor
Адріано Малабарба
Ромео Чабаті
Жанбатіста Панцоне
Алесандра Марія Маразі
Original Assignee
Біосерч Італіа С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA41283(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Біосерч Італіа С.П.А. filed Critical Біосерч Італіа С.П.А.
Publication of UA41283C2 publication Critical patent/UA41283C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Спосiб виробництва горiлки "Донецька" передбачає приготування виправленої води, цукрового розчину, купажування рецептурних компонентiв, фiльтрацiю купажу, коректування його міцності i розливу, причому розчинення рецептурної кiлькостi цукру в розрахунковiй кiлькостi виправленої води здiйснюють при температурi 28-32 °С i перемiшуваннi, а змiшування в купажнiй ємкостi цукрового розчину із спиртом етиловим ректіфікованим - при масовому співвідношенні цукру і спирту ректифікованого (0,84-1,16) - 155.
UA94005300A 1991-07-29 1992-07-14 Похідні антибіотику а 40926 та способи їх одержання UA41283C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12
PCT/EP1992/001594 WO1993003060A1 (en) 1991-07-29 1992-07-14 Amide derivatives of antibiotic a 40926

Publications (1)

Publication Number Publication Date
UA41283C2 true UA41283C2 (uk) 2001-09-17

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005300A UA41283C2 (uk) 1991-07-29 1992-07-14 Похідні антибіотику а 40926 та способи їх одержання

Country Status (24)

Country Link
EP (2) EP0596929B1 (uk)
JP (1) JP3418762B2 (uk)
KR (1) KR100242682B1 (uk)
AT (1) ATE125551T1 (uk)
AU (1) AU666862B2 (uk)
BG (1) BG61124B2 (uk)
CA (1) CA2109601C (uk)
CZ (1) CZ285703B6 (uk)
DE (1) DE69203724T2 (uk)
DK (1) DK0596929T3 (uk)
ES (1) ES2075709T3 (uk)
FI (1) FI112662B (uk)
GR (1) GR3017897T3 (uk)
HU (2) HU223946B1 (uk)
IE (1) IE68420B1 (uk)
IL (1) IL102623A (uk)
MX (1) MX9204394A (uk)
NO (1) NO314150B1 (uk)
NZ (1) NZ243735A (uk)
PL (1) PL171813B1 (uk)
RU (1) RU2125058C1 (uk)
TW (1) TW218021B (uk)
UA (1) UA41283C2 (uk)
WO (1) WO1993003060A1 (uk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
KR100430202B1 (ko) * 1995-07-05 2004-09-18 아벤티스 벌크 에스.피.에이. 등전성 집속에 의한 달바 헵티드 항생제의 정제
DE69708293T2 (de) * 1996-04-23 2002-05-02 Biosearch Italia S.P.A., Gerenzano Chemisches Verfahren zur Herstellung von Amidderivaten von A 40926 Antibiotikum
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
HU230190B1 (hu) 1998-12-23 2015-09-28 Theravance, Inc Glikopeptidszármazékok és ezeket tartalmazó gyógyászati kompozíciók
MY123217A (en) * 1998-12-23 2006-05-31 Theravance Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003298662A1 (en) 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1641480A1 (en) 2003-05-27 2006-04-05 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
ATE381957T1 (de) 2003-07-22 2008-01-15 Theravance Inc Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel
TW200626616A (en) 2004-11-29 2006-08-01 Univ Nagoya Nat Univ Corp Monomer derivatives of glycopeptide antibiotics
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
CA2710417A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivatives
EP4274842A1 (en) * 2021-01-11 2023-11-15 Xellia Pharmaceuticals ApS Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
DE68925806T2 (de) * 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
CA2095725A1 (en) * 1990-12-05 1992-06-06 Adriano Malabarba 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics and a process for preparing them
HU210665B (en) * 1991-03-27 1995-06-28 Lepetit Spa Process for producing ester derivatives of the antibiotic a 40926 and pharmaceutical compositions containing them as active component

Also Published As

Publication number Publication date
JP3418762B2 (ja) 2003-06-23
CA2109601C (en) 2002-07-02
IL102623A0 (en) 1993-01-14
CZ285703B6 (cs) 1999-10-13
DE69203724D1 (de) 1995-08-31
ES2075709T3 (es) 1995-10-01
HU211347A9 (en) 1995-11-28
TW218021B (uk) 1993-12-21
KR100242682B1 (ko) 2000-02-01
EP0596929B1 (en) 1995-07-26
WO1993003060A1 (en) 1993-02-18
FI112662B (fi) 2003-12-31
HU9400256D0 (en) 1994-05-30
EP0525499A1 (en) 1993-02-03
HU223946B1 (hu) 2005-03-29
MX9204394A (es) 1993-01-29
IE922451A1 (en) 1993-02-10
AU666862B2 (en) 1996-02-29
NO934722L (no) 1994-02-14
JPH06509347A (ja) 1994-10-20
FI940394A0 (fi) 1994-01-26
DK0596929T3 (da) 1995-09-11
DE69203724T2 (de) 1996-01-18
BG61124B2 (bg) 1996-11-29
IE68420B1 (en) 1996-06-12
EP0596929A1 (en) 1994-05-18
IL102623A (en) 1996-10-16
GR3017897T3 (en) 1996-01-31
CZ19294A3 (en) 1994-11-16
NO314150B1 (no) 2003-02-03
CA2109601A1 (en) 1993-02-18
ATE125551T1 (de) 1995-08-15
NO934722D0 (no) 1993-12-20
RU2125058C1 (ru) 1999-01-20
FI940394A (fi) 1994-01-26
HUT66080A (en) 1994-09-28
AU2326292A (en) 1993-03-02
PL171813B1 (pl) 1997-06-30
NZ243735A (en) 1995-01-27

Similar Documents

Publication Publication Date Title
UA41283C2 (uk) Похідні антибіотику а 40926 та способи їх одержання
RU94013457A (ru) Амидные производные антибиотика а 40926
DE69434136D1 (de) Dolastatin-derivate
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
DK0582810T3 (da) Nye 7-(substitueret)-8-(substitueret)-9-(substitueret amino)-6-demethyl-6-deoxytetracycliner som antibiotiske midler
AU2415292A (en) Novel tetrapeptide derivative
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
ES2059285T1 (es) Un metodo mejorado para la preparacion de ciertos antibioticos beta-lactamicos.
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
ES2173391T3 (es) Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
NO890567D0 (no) Anthracyklin-derivater.
ES2058737T3 (es) Derivados semisinteticos con actividad inmunomoduladora, apropiados para administracion oral o parenteral.
ES2086651T3 (es) Nuevos compuestos, denominados "leustroducsinas", su preparacion y sus utilizaciones terapeuticas.
FI951378A (fi) N-asetyyli-neuramiinihapon johdannaisten synteesi
ATE90685T1 (de) Disaccharidderivate.
TW344743B (en) Therapeutic nucleosides
ATE140460T1 (de) Echinocandin-b-derivat
DK211289A (da) Polyether-antibiotikum benaevnt a82810 og fremgangsmaade til fremstilling deraf
KR900006517A (ko) 항생제 pb-6042류
HUT57718A (en) Process for producing thiourea derivative
EP0596112A4 (en) Macrolide compound and its preparation.
EP0404104A3 (en) Angolamycin derivatives